Literature DB >> 24820417

Fbw7 targets GATA3 through cyclin-dependent kinase 2-dependent proteolysis and contributes to regulation of T-cell development.

Kyoko Kitagawa, Kiyoshi Shibata, Akinobu Matsumoto, Masaki Matsumoto, Tatsuya Ohhata, Keiichi I Nakayama, Hiroyuki Niida, Masatoshi Kitagawa.   

Abstract

Proper development of T cells depends on lineage-specific regulators controlled transcriptionally and posttranslationally to ensure precise levels at appropriate times. Conditional inactivation of F-box protein Fbw7 in mouse T-cell development resulted in reduced thymic CD4 single-positive (SP) and splenic CD4(+) and CD8(+) cell proportions. Fbw7 deficiency skewed CD8 SP lineage differentiation, which exhibited a higher incidence of apoptosis. Similar perturbations during development of CD8-positive cells were reported with transgenic mice, which enforced GATA3 (T-cell differentiation regulator) expression throughout T-cell development. We observed augmented GATA3 in CD4/CD8 double negative (DN) stage 4, CD4 SP, and CD8 SP lineages in Fbw7-deficient thymocytes. Using overexpressed proteins in cultured cells, we demonstrated that Fbw7 bound to, ubiquitylated, and destabilized GATA3. Two Cdc4 phosphodegron (CPD) candidate sequences, consensus Fbw7 recognition domains, were identified in GATA3, and phosphorylation of Thr-156 in CPD was required for Fbw7-mediated ubiquitylation and degradation. Phosphorylation of GATA3 Thr-156 was detected in mouse thymocytes, and cyclin-dependent kinase 2 (CDK2) was identified as a respondent for phosphorylation at Thr-156. These observations suggest that Fbw7-mediated GATA3 regulation with CDK2-mediated phosphorylation of CPD contributes to the precise differentiation of T-cell lineages.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24820417      PMCID: PMC4097664          DOI: 10.1128/MCB.01549-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

Review 1.  The regulation of CD4 and CD8 coreceptor gene expression during T cell development.

Authors:  W Ellmeier; S Sawada; D R Littman
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

Review 2.  GSK3 inhibitors: development and therapeutic potential.

Authors:  Philip Cohen; Michel Goedert
Journal:  Nat Rev Drug Discov       Date:  2004-06       Impact factor: 84.694

3.  Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3.

Authors:  Kittipong Maneechotesuwan; Yao Xin; Kazuhiro Ito; Elen Jazrawi; Kang-Yun Lee; Omar S Usmani; Peter J Barnes; Ian M Adcock
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

4.  Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3.

Authors:  Tom Taghon; Mary A Yui; Ellen V Rothenberg
Journal:  Nat Immunol       Date:  2007-07-01       Impact factor: 25.606

5.  E2A transcription factors limit expression of Gata3 to facilitate T lymphocyte lineage commitment.

Authors:  Wei Xu; Tiffany Carr; Kevin Ramirez; Stephanie McGregor; Mikael Sigvardsson; Barbara L Kee
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

6.  Chemokine C receptor 7 expression and protection of circulating CD8+ T lymphocytes from apoptosis.

Authors:  Jeong-Whun Kim; Robert L Ferris; Theresa L Whiteside
Journal:  Clin Cancer Res       Date:  2005-11-01       Impact factor: 12.531

7.  Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus.

Authors:  R W Hendriks; M C Nawijn; J D Engel; H van Doorninck; F Grosveld; A Karis
Journal:  Eur J Immunol       Date:  1999-06       Impact factor: 5.532

8.  sel-10, a negative regulator of lin-12 activity in Caenorhabditis elegans, encodes a member of the CDC4 family of proteins.

Authors:  E J Hubbard; G Wu; J Kitajewski; I Greenwald
Journal:  Genes Dev       Date:  1997-12-01       Impact factor: 11.361

9.  Ras-ERK MAPK cascade regulates GATA3 stability and Th2 differentiation through ubiquitin-proteasome pathway.

Authors:  Masakatsu Yamashita; Ryo Shinnakasu; Hikari Asou; Motoko Kimura; Akihiro Hasegawa; Kahoko Hashimoto; Naoya Hatano; Masato Ogata; Toshinori Nakayama
Journal:  J Biol Chem       Date:  2005-06-23       Impact factor: 5.157

10.  The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.

Authors:  M Kitagawa; H Higashi; H K Jung; I Suzuki-Takahashi; M Ikeda; K Tamai; J Kato; K Segawa; E Yoshida; S Nishimura; Y Taya
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

View more
  16 in total

Review 1.  Cytokines, Transcription Factors, and the Initiation of T-Cell Development.

Authors:  Hiroyuki Hosokawa; Ellen V Rothenberg
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

Review 2.  The role of aurora A and polo-like kinases in high-risk lymphomas.

Authors:  Carlos Murga-Zamalloa; Kedar V Inamdar; Ryan A Wilcox
Journal:  Blood Adv       Date:  2019-06-11

Review 3.  Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication.

Authors:  Mingjing He; Zhuan Zhou; George Wu; Qianming Chen; Yong Wan
Journal:  Pharmacol Ther       Date:  2017-03-06       Impact factor: 12.310

4.  Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.

Authors:  Tomomi Nakajima; Kyoko Kitagawa; Tatsuya Ohhata; Satoshi Sakai; Chiharu Uchida; Kiyoshi Shibata; Naoko Minegishi; Kanae Yumimoto; Keiichi I Nakayama; Kazuma Masumoto; Fuminori Katou; Hiroyuki Niida; Masatoshi Kitagawa
Journal:  J Biol Chem       Date:  2015-02-10       Impact factor: 5.157

Review 5.  Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy.

Authors:  Liangliang Xing; Leidi Xu; Yong Zhang; Yinggang Che; Min Wang; Yongxiang Shao; Dan Qiu; Honglian Yu; Feng Zhao; Jian Zhang
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

Review 6.  Physiological functions of FBW7 in cancer and metabolism.

Authors:  Kouhei Shimizu; Naoe Taira Nihira; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Cell Signal       Date:  2018-02-21       Impact factor: 4.315

7.  Akt1-mediated Gata3 phosphorylation controls the repression of IFNγ in memory-type Th2 cells.

Authors:  Hiroyuki Hosokawa; Tomoaki Tanaka; Yusuke Endo; Miki Kato; Kenta Shinoda; Akane Suzuki; Shinichiro Motohashi; Masaki Matsumoto; Keiichi I Nakayama; Toshinori Nakayama
Journal:  Nat Commun       Date:  2016-04-07       Impact factor: 14.919

8.  Participation of GATA-3 in regulation of bone healing through transcriptional upregulation of bcl-xL expression.

Authors:  Mei-Hsiu Liao; Pei-I Lin; Wei-Pin Ho; Wing P Chan; Ta-Liang Chen; Ruei-Ming Chen
Journal:  Exp Mol Med       Date:  2017-11-24       Impact factor: 8.718

Review 9.  The emerging role of GATA transcription factors in development and disease.

Authors:  Marjolein H F M Lentjes; Hanneke E C Niessen; Yoshimitsu Akiyama; Adriaan P de Bruïne; Veerle Melotte; Manon van Engeland
Journal:  Expert Rev Mol Med       Date:  2016-03-08       Impact factor: 5.600

Review 10.  Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis.

Authors:  Jun Cao; Ming-Hua Ge; Zhi-Qiang Ling
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.